Medicine & Life Sciences
Cost-Benefit Analysis
100%
Nephrotic Syndrome
78%
Prednisolone
71%
Respiratory Tract Infections
64%
Resource Allocation
55%
Economics
53%
Steroids
51%
Systematic Reviews
51%
Population Health
37%
Proxy
36%
Placebos
33%
Psychometrics
32%
Delivery of Health Care
31%
Child
30%
Parkinson Disease
29%
Public Health
28%
United States Public Health Service
28%
Recurrence
27%
Decision Making
27%
Health
26%
Costs and Cost Analysis
24%
Obesity
24%
Randomized Controlled Trials
23%
Education
23%
Quality-Adjusted Life Years
23%
Quality of Life
21%
Health Care Outcome Assessment
18%
Consensus Development Conferences
18%
England
17%
Taxes
15%
Local Government
15%
Qualitative Research
13%
Budgets
13%
Disease Management
12%
Population
12%
Long-Term Care
12%
Health Care Costs
12%
Feasibility Studies
12%
Netherlands
11%
Reproducibility of Results
10%
insulin receptor-related receptor
10%
Occupational Therapy
10%
Deep Brain Stimulation
10%
Respiratory System
9%
Organizations
9%
Immunosuppressive Agents
8%
Structural Models
8%
Therapeutics
8%
Elasticity
7%
Leisure Activities
7%
Social Sciences
allocation decision
64%
economics
44%
evaluation
34%
construct validity
33%
psychometrics
29%
resources
25%
public health
25%
health care
24%
costs
23%
life years
23%
public health services
21%
quality of life
18%
Healthcare
17%
well-being
17%
decision making
17%
evidence
16%
health
16%
management
16%
system change
16%
taxes
15%
equity
14%
relapse
13%
time
12%
funding
11%
willingness to pay
11%
Netherlands
9%
taxation
9%
utility analysis
9%
speaking
8%
deliberation
8%
demographic situation
7%
budget
6%
qualitative research
6%
economist
6%
Business & Economics
Obesity
39%
Economics
17%
Systems Change
13%
Local Government
13%
Cost-effectiveness
8%
Physical Health
6%
Equity
6%
Health Outcomes
6%
Economic Evaluation
6%
Efficiency Gains
6%
Systems Approach
5%
Hub
5%
Economic Development
5%
Economists
5%
Mental Health
5%
Guidance
5%